Cargando…

A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety

Background and study aims  Oral sulphate solution (OSS) is a sulphate-based, low-volume bowel cleansing preparation taken in two doses of 500 mL, each followed by 1000mL of water or clear liquid. The primary objective of this observational study was to document compliance with the recommended hydrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Regula, Jaroslaw, Spaander, Manon C.W., Suchanek, Stepan, Kornowski, Anne, Perrot, Valerie, Fischbach, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055619/
https://www.ncbi.nlm.nih.gov/pubmed/32140554
http://dx.doi.org/10.1055/a-1090-7289
_version_ 1783503394942484480
author Regula, Jaroslaw
Spaander, Manon C.W.
Suchanek, Stepan
Kornowski, Anne
Perrot, Valerie
Fischbach, Wolfgang
author_facet Regula, Jaroslaw
Spaander, Manon C.W.
Suchanek, Stepan
Kornowski, Anne
Perrot, Valerie
Fischbach, Wolfgang
author_sort Regula, Jaroslaw
collection PubMed
description Background and study aims  Oral sulphate solution (OSS) is a sulphate-based, low-volume bowel cleansing preparation taken in two doses of 500 mL, each followed by 1000mL of water or clear liquid. The primary objective of this observational study was to document compliance with the recommended hydration guidelines in a representative sample of the European population. Patients and methods  Prospective, non-interventional, multicentre study (NCT02630680, EUPAS9361) in patients prescribed OSS for colonoscopy preparation in routine clinical practice in Europe. Patients were included according to pre-agreed consecutive enrolment rules. Patients recorded the volume of OSS and water or clear liquid intake, and occurrence of adverse events (AEs). Compliance with hydration was calculated as a ratio of actual volume of water/clear liquid taken versus prescribed 2,000 mL, and non-compliance defined as < 75 % intake. Colon cleansing level was assessed on a 4-point scale. Results  Between October 2015 and January 2017, 1,281 patients were recruited in 16 centres in four European countries (safety population n = 1,206; registry population n = 1,177). Of patients, 94.5 % were ≥ 75 % and 86.8 % 100 % compliant with hydration guidelines. Patients took an average of 96.8 % of the recommended OSS volume; 46 patients (3.9 %) were non-compliant. Colon cleansing levels were good-to-excellent in 87.6 % of patients. Three hundred and twenty-nine patients (27.3 %) experienced 758 treatment-related AEs, mostly gastrointestinal (82.9 %), all were mild-to-moderate. Non-compliant patients had no AEs suggestive of dehydration. Conclusion  In this non-interventional study in a real-life setting, treatment compliance with hydration guidelines was good-to-excellent in 94.5 % of patients receiving OSS. The safety profile of OSS was similar to the prescribing information. TRIAL REGISTRATION: Observational study EUPAS9361 at www.encepp.eu
format Online
Article
Text
id pubmed-7055619
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher © Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-70556192020-03-05 A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety Regula, Jaroslaw Spaander, Manon C.W. Suchanek, Stepan Kornowski, Anne Perrot, Valerie Fischbach, Wolfgang Endosc Int Open Background and study aims  Oral sulphate solution (OSS) is a sulphate-based, low-volume bowel cleansing preparation taken in two doses of 500 mL, each followed by 1000mL of water or clear liquid. The primary objective of this observational study was to document compliance with the recommended hydration guidelines in a representative sample of the European population. Patients and methods  Prospective, non-interventional, multicentre study (NCT02630680, EUPAS9361) in patients prescribed OSS for colonoscopy preparation in routine clinical practice in Europe. Patients were included according to pre-agreed consecutive enrolment rules. Patients recorded the volume of OSS and water or clear liquid intake, and occurrence of adverse events (AEs). Compliance with hydration was calculated as a ratio of actual volume of water/clear liquid taken versus prescribed 2,000 mL, and non-compliance defined as < 75 % intake. Colon cleansing level was assessed on a 4-point scale. Results  Between October 2015 and January 2017, 1,281 patients were recruited in 16 centres in four European countries (safety population n = 1,206; registry population n = 1,177). Of patients, 94.5 % were ≥ 75 % and 86.8 % 100 % compliant with hydration guidelines. Patients took an average of 96.8 % of the recommended OSS volume; 46 patients (3.9 %) were non-compliant. Colon cleansing levels were good-to-excellent in 87.6 % of patients. Three hundred and twenty-nine patients (27.3 %) experienced 758 treatment-related AEs, mostly gastrointestinal (82.9 %), all were mild-to-moderate. Non-compliant patients had no AEs suggestive of dehydration. Conclusion  In this non-interventional study in a real-life setting, treatment compliance with hydration guidelines was good-to-excellent in 94.5 % of patients receiving OSS. The safety profile of OSS was similar to the prescribing information. TRIAL REGISTRATION: Observational study EUPAS9361 at www.encepp.eu © Georg Thieme Verlag KG 2020-03 2020-02-21 /pmc/articles/PMC7055619/ /pubmed/32140554 http://dx.doi.org/10.1055/a-1090-7289 Text en https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Regula, Jaroslaw
Spaander, Manon C.W.
Suchanek, Stepan
Kornowski, Anne
Perrot, Valerie
Fischbach, Wolfgang
A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety
title A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety
title_full A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety
title_fullStr A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety
title_full_unstemmed A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety
title_short A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety
title_sort european, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055619/
https://www.ncbi.nlm.nih.gov/pubmed/32140554
http://dx.doi.org/10.1055/a-1090-7289
work_keys_str_mv AT regulajaroslaw aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT spaandermanoncw aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT suchanekstepan aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT kornowskianne aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT perrotvalerie aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT fischbachwolfgang aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT regulajaroslaw europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT spaandermanoncw europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT suchanekstepan europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT kornowskianne europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT perrotvalerie europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT fischbachwolfgang europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety
AT europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety